Transparency requirement (FSA/AKG)

According to the FSA e. V. (Voluntary Self-Regulation for the Pharmaceutical Industry), the conditions and scope of support from member companies must be presented transparently to participants, both when announcing and conducting the congress.

In accordance with the guidelines of the AKG e. V. (Arzneimittel und Kooperation im Gesundheitswesen e.V.), member companies must work towards ensuring that their support is disclosed by the organiser both when announcing the congress and during its implementation. The publication of the type and scope of the overall support does not represent an obligation for the AKG member companies and is voluntary here.

Industry partnerAmountPurpose of the support
Kaneka Pharma Europe N.V.10.494,96 €Goldponsoring, virtual exhibition
medicap clinic GmbH2.344,20 €virtual exhibition
DIAMED Medizintechnik GmbH3.026,40 €virtual exhibition, sponsoring newsletter
Pakumed medical product gmbh1.560,00 €virtual exhibition
AMGEN GmbH3.000,00 €virtual exhibition
Pentracor GmbH8.500,00 €Goldsponsoring, virtual exhibition,  Symposium
Daiichi Sankyo2.500,00 €virtual exhibition
Sanofi-Aventis Deutschland GmbH2.500,00 €virtual exhibition
Sobi – Swedish Orphan Biovitrum GmbH2.500,00 €virtual exhibition
B. Braun Avitum AG2.500,00 €virtual exhibition

The industry partners confirm that the support service is not intended to influence sales transactions, in particular procurement transactions/pricing, or the prescribing behaviour of the medical facility, nor are there any expectations in this regard.